Skip to main content
Livermore
Livermore
ZHEN

BNP Paribas Arbitrage, SA

SEC CIK
0001166588
Latest filing
Aug 13, 2026

AVTX holding history

Avalo Therapeutics, Inc. in every 13F filed by BNP Paribas Arbitrage, SA, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AVTX overviewAll 13F holders of AVTXFull Q2 2026 holdings

Shares (Q2 2026)
134,087
Value
$2.48M
% of portfolio
<0.1%
Quarters held
13
Since Q1 2021
Holdings of AVTX by BNP Paribas Arbitrage, SA, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026134,087$2.48M<0.1%−288,694−68.3%ReducedHolders
Q1 2026422,781$6.31M<0.1%+225,034+113.8%AddedHolders
Q4 2025197,747$3.59M<0.1%+197,742+3,954,840.0%AddedHolders
Q3 20255$64<0.1%00.0%UnchangedHolders
Q2 20255$25<0.1%+1+25.0%AddedHolders
Q1 20254$32<0.1%00.0%UnchangedHolders
Q4 20244$30<0.1%00.0%UnchangedHolders
Q3 20244$38<0.1%00.0%UnchangedHolders
Q2 20244$50<0.1%00.0%UnchangedHolders
Q1 20244$87<0.1%+4NewHolders
Q4 20220$00.0%−717−100.0%Sold outHolders
Q3 2022717$2.38K<0.1%+717NewHolders
Q3 20210$00.0%−2,982−100.0%Sold outHolders
Q2 20212,982$9.75K<0.1%−2,774−48.2%ReducedHolders
Q1 20215,756$17.4K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.